Price of Ceritinib/Ceritinib

Ceritinib/Ceritinib (Ceritinib) is an oral anti-cancer drug that belongs to the category of tyrosine kinase inhibitors. It is developed and produced by Novartis Pharmaceuticals. This drug is primarily used to treat patients with a specific type of non-small cell lung cancer (NSCLC) that is positive for the ALK (tyrosine kinase) fusion.

Ceritinib/Ceritinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically, but the price is high. Please consult your local pharmacy for details. Foreign original drugs are divided into original drugs and generic drugs. Foreign original drugs are mainly Swiss Novartis original drugs. Specification150mg*150The price is about13,500 yuan. Generic drugs mainly include Bangladeshi version, with specifications of 150mg*30 and the price is around 1,300 yuan. The ingredients of original drugs and generic drugs are basically the same.

ALK is a protein that is involved in cell signaling and regulating cell growth under normal circumstances. However, in some patients with non-small cell lung cancer, due to genetic mutations or fusions, the ALK protein becomes abnormal and promotes abnormal growth and spread of cancer cells. Ceritinib/Ceritinib works by inhibiting this abnormal ALK activity, thereby preventing the proliferation and spread of cancer cells.

Ceritinib/Ceritinib showed significant therapeutic efficacy in clinical trials for patients with ALK fusion-positive non-small cell lung cancer. It is effective and was approved by the U.S. Food and Drug Administration (FDA) in 2014, becoming one of the treatment options available for doctors to prescribe.

Althoughceritinib/ceritinibIt is a promising treatment, but it may also cause side effects such as nausea, vomiting, diarrhea, fatigue, etc. Therefore, when using this drug for treatment, doctors will closely monitor the patient's response and make dose adjustments or take other measures as necessary to ensure that the patient gets the best results while minimizing adverse reactions. During treatment, the medical team works closely with the patient to provide comprehensive support and care.